Heart attack and cancer? Here's the cure that prevents them.

Canakinumb, an antipsyst, has been used as a tester in more than 10,000 patients, all of whom had heart attacks.

This drug lowers for a fourth risk of heart attacks, halves the chances of dying from cancer, also protects man from arthritis.

These cholesterol - containing drugs have begun to give rise to millions of people who are considered at risk of heart disease, since heart attacks in humans are most often caused by cholesterol.

This drug is prescribed every three months and reduces the risk of heart attacks by 15 percent, the passing of time.

Paul Ridker, professor of medicine at Harvard, yesterday at the Barcelona European Society of Cardiology Congress, has said that this discovery is a major step in the fight against cancer and heart disease, and that it is the outcome of a discovery after two decades of work.

“for the first time we are able to show ultimately that lowering inflammation independent of cholesterol reduces cardiovascular risk”, he said.